Zentiva, one of the leading developers and suppliers of prescription medicines and consumer brands has launched 15 mg and 30 mg Buspirone tablets.
This medication is indicated for the treatment of short-term management of anxiety disorders and the relief of symptoms of anxiety with or without accompanying symptoms of depression.
Luke Hart, General Manager commented, “Zentiva is excited to announce this new addition to our Value Added Medicines portfolio, continuing to meet the unfulfilled needs of patients.”
He continues, “the launch of our 15mg and 30mg Buspirone Tablets will enable more flexible and accurate dosing – allowing for simple and convenient dosing regimens for patients with anxiety disorders.”
